Thomas Stoll
- Rheumatology top 1%
- Systemic Lupus Erythematosus Research 17
- Rheumatoid Arthritis Research and Therapies 5
-
- Spine and Intervertebral Disc Pathology 8
- Systemic Sclerosis and Related Diseases 8
- Pharmacology top 2%
- Musculoskeletal pain and rehabilitation 5
- Psychiatry and Mental health top 5%
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases 5
-
- Bone fractures and treatments 6
-
- Spinal Fractures and Fixation Techniques 5
Thomas Stoll
81 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 148
- Rheumatology 915
- Pathology and Forensic Medicine 793
- Pharmacology 464
- Psychiatry and Mental health 375
- Immunology 486
Countries citing papers authored by Thomas Stoll
This map shows the geographic impact of Thomas Stoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Stoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Stoll more than expected).
Fields of papers citing papers by Thomas Stoll
This network shows the impact of papers produced by Thomas Stoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Stoll. The network helps show where Thomas Stoll may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Stoll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 14 | |
| 4 | 2018 | 17 | |
| 5 | 2018 | 1 | |
| 6 | 2017 | 104 | |
| 7 | 2016 | 34 | |
| 8 | 2014 | 28 | |
| 9 | [Towards the Swiss systemic lupus erythematosus cohort study (SSCS)]. | 2009 | 12 |
| 10 | 2009 | 26 | |
| 11 | 2005 | 61 | |
| 12 | 2004 | 20 | |
| 13 | 2003 | 5 | |
| 14 | 2002 | 102 | |
| 15 | 2000 | 122 | |
| 16 | 2000 | 43 | |
| 17 | Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus. | 1997 | 67 |
| 18 | 1996 | 14 | |
| 19 | [Systemic sclerosis (scleroderma): etiology and pathogenesis--where are we today?]. | 1994 | 3 |
| 20 | 1993 | 103 |
About Thomas Stoll
Thomas Stoll is a scholar working on Rheumatology, Pathology and Forensic Medicine, Genetics, Psychiatry and Mental health and Rehabilitation, having authored 83 papers that have together received 3.2k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (17 papers), Spine and Intervertebral Disc Pathology (8 papers), Systemic Sclerosis and Related Diseases (8 papers), Bone fractures and treatments (6 papers), Spinal Fractures and Fixation Techniques (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Musculoskeletal pain and rehabilitation (5 papers). The work is most often cited by research in Rheumatology (915 citations), Pathology and Forensic Medicine (793 citations), Pharmacology (464 citations), Psychiatry and Mental health (375 citations) and Immunology (486 citations). Thomas Stoll has collaborated with scholars based in Switzerland, Australia and Germany. Frequent co-authors include David Isenberg, Othmar Schwarzenbach, Gilles Dubois, Burkhardt Seifert, Gerold Stucki, J Malik, S Pyke, Erika Omega Huber, Richard Klaghofer and Stefan Büchi. Their work appears in journals such as Annals of the Rheumatic Diseases, PLoS ONE, Scientific Reports, Molecular & Cellular Proteomics and Journal of Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.